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Sonic hedgehog (Shh) signal, mediated by the Gli family of transcription factors, plays an essential role
in the growth and patterning of the limb. Through analysis of the early limb bud transcriptome, we
identiﬁed a posteriorly-enriched gene, Hyaluronic Acid Synthase 2 (Has2), which encodes a key enzyme
for the synthesis of hyaluronan (HA), as a direct target of Gli transcriptional regulation during early
mouse limb development. Has2 expression in the limb bud is lost in Shh null and expanded anteriorly in
Gli3 mutants. We identiﬁed an 3 kb Has2 promoter fragment that contains two strong Gli-binding
consensus sequences, and mutation of either site abrogated the ability of Gli1 to activate Has2 promoter
in a cell-based assay. Additionally, this promoter fragment is sufﬁcient to direct expression of a reporter
gene in the posterior limb mesenchyme. Chromatin immunoprecipitation of DNA-Gli3 protein
complexes from limb buds indicated that Gli3 strongly binds to the Has2 promoter region, suggesting
that Has2 is a direct transcriptional target of the Shh signaling pathway. We also showed that Has2
conditional mutant (Has2cko) hindlimbs display digit-speciﬁc patterning defects with longitudinally
shifted phalangeal joints and impaired chondrogenesis. Has2cko limbs show less capacity for mesench-
ymal condensation with mislocalized distributions of chondroitin sulfate proteoglycans (CSPGs),
aggrecan and link protein. Has2cko limb phenotype displays striking resemblance to mutants with
defective chondroitin sulfation suggesting tight developmental control of HA on CSPG function.
Together, our study identiﬁes Has2 as a novel downstream target of Shh signaling required for joint
patterning and chondrogenesis.
& 2013 Elsevier Inc. All rights reserved.Introduction
The Hedgehog family of secreted proteins control growth and
patterning during embryogenesis. Sonic hedgehog (Shh) is the
most studied vertebrate member and its role has been extensively
investigated in the context of limb development. The vertebrate
limb originates from the lateral plate mesoderm as a bud-like
outgrowth of mesenchymal cells surrounded by an ectodermal
layer. Shh expression in the posterior margin of the limb bud
deﬁnes the zone of polarizing activity, a signaling center that
regulates anterior–posterior polarity and distal outgrowth of the
limb through a positive feedback interaction with ﬁbroblast
growth factor (Fgf) secreted from the apical ectodermal ridge
(Niswander et al., 1994; Riddle et al., 1993). This positive loop
stabilizes Shh expression, permitting proliferation and survival of
mesenchymal precursors that preﬁgure digit numbers andll rights reserved.
iang).pattern (Towers et al., 2011; Zhu et al., 2008). Accordingly, the
global inactivation of Shh leads to truncations of all distal skeletal
elements except for a single un-ossiﬁed digit 1 (Chiang et al.,
2001).
The response to Shh signaling is mediated by three Gli
transcription factor family members. Gli1 functions solely as a
transcriptional activator whereas Gli2 and Gli3 possess both
activator and repressor activities that are regulated by Shh
signaling. Genetic studies indicated that Gli1 expression is
dependent on Gli2 and Gli3 activator activities (Bai et al., 2004;
Motoyama et al., 2003). In contrast, Gli3, and to a limited extent
Gli2, are constitutively cleaved into truncated repressor forms
while Shh signaling counters this process and converts them to
labile activators (Litingtung et al., 2002; Pan et al., 2006; Wang
et al., 2000). The loss of Gli3 function leads to polydactyly with
defective digit pattern and identity, resembling that of Shh;Gli3 or
Gli2;Gli3 double mutants when both repressor and activator
activities are abrogated (Bowers et al., 2012; Litingtung et al.,
2002; te Welscher et al., 2002). While these observations under-
score the importance of Gli activities in the control of limb
J. Liu et al. / Developmental Biology 375 (2013) 160–171 161development, much less is known about downstream targets that
mediate their functions. Recent genome-wide chromatin immu-
noprecipitation (ChIP) studies using mouse limb buds derived
from transgene expressing an epitope-tagged Gli3 have identiﬁed
over two hundred putative direct Gli target genes, highlighting
the complexity of the regulatory landscape (Vokes et al., 2008).
Using genome-wide microarray analysis of dissected anterior and
posterior halves of mouse limb buds, we identiﬁed Hyaluronic acid
synthase 2 (Has2) as a posteriorly-enriched gene. Although Has2 is one
of three members of the Has family, it encodes the enzyme regulating
hyaluronan (HA) biosynthesis during mouse embryogenesis as Has2
null mutants fail to produce HA and die at E9.5-10; in contrast, Has1
and/or Has3 null mutants do not exhibit obvious defects, are viable
and fertile (Camenisch et al., 2000). HA is a major glycosaminoglycan
component of the extracellular matrix, and together with chondroitin
sulfate proteoglycans (CSPGs), forms an aggregate network stabilized
by link proteins. This supramolecular complex is thought to regulate
various cell functions by promoting adhesion, migration, proliferation
and signal transduction (Day and Prestwich, 2002; Lee and Spicer,
2000; Toole, 2004; Turley et al., 2002). Embryos in which Has2 has
been conditionally deleted from the limb bud using Prx1-cre display
partial proximal phalange duplications with defective joints that lack
distinct cavities (Matsumoto et al., 2009). However, null mutations
that disrupt CSPG function showed earlier, more severe phalangeal
patterning defects (Sohaskey et al., 2008; Wilson et al., 2012),
suggesting either that the functional complex can still be retained
in the absence of HA or that the less severe phenotype in Has2
conditional knockout represents a partial loss of function.
In this study, we showed that Has2 expression is dependent on
Shh signaling and is ectopically activated in Gli3 mutant limb
buds. Furthermore, we identiﬁed two cooperative Gli-binding
sites (GBS1 and GBS2) within 3 kb of the Has2 genomic region,
and mutating these sites abolished Gli1-mediated reporter acti-
vation in a cell based assay. Chromatin immunoprecipitation of
mouse limb buds showed that Gli3 strongly interacts with the
region encompassing both GBS1 and GBS2. We also showed that
the Hoxb6-cre driven Has2 conditional mutants exhibit severe
patterning defects within digits where joints are shifted perpen-
dicularly, closely resembling mutants with defective chondroitin
sulfate synthesis or metabolism. Therefore, our ﬁndings place
Has2 as an important downstream effector of Shh signaling in the
developing limb that is required to establish joint patterning
within digits by stabilizing HA-CSPG complexes.Materials and methods
Gene expression proﬁling analysis
E10.5 limb buds from 8 litters, with 12–15 embryos per litter,
were collected in cold PBS and bisected into anterior and posterior
halves. Total RNAs were extracted from anterior and posterior halves
using Trizol and puriﬁed using a RNeasy Mini kit (Qiagen, CA).
Microarray analysis on 300 mg RNA from each sample was carried
out by the Vanderbilt Microarray Core facility using AffymetrixMouse
Exon 1.0 ST Array. The microarray data has been deposited in the
Gene Expression Omnibus (GEO) database (GSE41691). RNA samples
were also reverse transcribed using iScript cDNA synthesis kit (Bio-
Rad, CA) and subjected to RT-PCR using primer sets as follows: Has2
Forward: 50-GTCCAAGTGCCTTACTGAAACTCCC-30; Has2 Reverse: 50-
GAGGATGTTCCAGATTTTACCCCTG-30; Gli1 Forward: 50-CTGGA-
GAACCTTAGGCTGGA-30; Gli1 Reverse: 50-CGGCTGACTGTGTAAG-
CAGA-30; Shh Forward: 50-TCTGTGATGAACCAGTGGCC-30; Shh
Reverse: 50-GCCACGGAGTTCTCTGCTTT-30 and Gapdh Forward: 50-
TTCACCACCATGGAGAAGGC-30; Gapdh Reverse: 50-GGCATG-
GACTGTGGTCATGA-30.Animals
The Has2 conditional targeting construct was generated using
the recombineering technique as previously described (Copeland
et al., 2001; Liu et al., 2003). Brieﬂy, a genomic region of 9.5 kb,
spanning exon 2 of Has2, was retrieved from a BAC clone (ID:
bMQ-150M3) into a diphthera toxin (DTA)-expressing plasmid by
recombineering. A loxp site was then inserted 50 bp upstream of
exon 2, followed by the integration of frt-neo-frt-loxp cassette
500 bp downstream of exon 2 via two rounds of recombineering.
The resulting Has2 targeting vector contained 50 and 30 homo-
logous arms, two loxp sequences ﬂanking exon 2, a ﬂp recombi-
nase removable neo cassette and the DTA gene (Fig. S1). To
generate Has2 conditional knockout allele, the NotI-linearized
targeting vector was electroporated into mouse R1 ES cells (Nagy
et al., 1993). Colonies that were negative for DTA and resistant to
G418 selection were further screened by Southern blotting after
HindIII digestion and analyzed by PCR to identify correctly
targeted ES clones (Fig. S1). Targeted ES cells were injected into
C57Bl6 blastocysts through the Vanderbilt Transgenic Mouse/
Embryonic Stem Cell Shared Resource, and strong chimeras were
subsequently backcrossed with Black Swiss mice to obtain germ-
line transmission mice that carried heterozygous Has2 targeted
allele. The neo selection cassette was then removed by crossing
the heterozygous mice with ﬂpe mice expressing ﬂp recombinase
(Rodriguez et al., 2000) to generate Has2ﬂox mice. Limb speciﬁc
deletion of Has2 was achieved by crossing to the HoxB6-cre line
(Lowe et al., 2000). Shh / and Gli3xt mice were as previously
described (Litingtung et al., 2002).
In situ hybridization and immunohistochemistry
Whole mount and section in situ hybridizations were per-
formed using digoxygenin-labeled riboprobes as previously
described (Li et al., 2006, 2008). Riboprobes were synthesized
using the digoxygenin RNA labeling kit (Roche). The probes used
were Has2 (IMAGE:30533251), Gdf5 (IMAGE:4190036), Wnt4
(Gavin et al., 1990), Chordin (Klingensmith et al., 1999), Sox9
(Ng et al., 1997), Noggin (McMahon et al., 1998), Col2a1 (Ng et al.,
1997) and Pgk1(IMAGE:6828087). Immunohistochemistry on
parafﬁn-embedded sections were performed as previously
described (Li et al., 2004). For detection of aggrecan and link
protein, tissue sections were ﬁrst treated with 0.1% trypsin for
10 min at 37 1C for enzymatic antigen retrieval, and then with
chondroitinase ABC (0.25 unit/ml; Sigma) for 30 min prior to
incubation with the primary antibodies. The primary antibodies
were rabbit anti-phosphorylated Erk1/2 (Cell signaling, 1:200),
rabbit anti-cleaved Caspase 3 (Cell Signaling, 1:200), rabbit anti-
phosphorylated Histone 3 (Millipore, 1:1000), mouse anti-CSPG
(DSHB, 9BA12, 1:10), mouse anti-aggrecan (DSHB, 12/21/1-C-6,
1:10) and mouse anti-link protein (DSHB, 9/30/8-A-4, 1:10).
Chromatin immunoprecipitation (ChIP)
The RosaGli3TFlagc/c line, which contains a Cre-inducible
3XFlag-tagged Gli3 repressor (Vokes et al., 2008), was crossed
with homozygous Prx1Cre mice (Logan et al., 2002). For each ChIP
experiment, we collected forelimbs and hindlimbs from a single
litter of eight or nine E11.5 embryos and performed ChIP with the
M2 anti-Flag monoclonal antibody (Sigma) as described pre-
viously (Vokes et al., 2007, 2008), performing a total of three
independent experiments. For a negative control, limb buds were
dissected from a single litter of E11.5 wildtype Swiss Webster
embryos and ChIP was performed using the same anti-Flag anti-
body. The occupancy of Gli3 repressor on the Has2 locus was
measured by realtime q-PCR using primer sets targeting different
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reaction containing SYBR Green Master Mix (ABI), and ran on the
ViiA7 Real-Time PCR System (ABI). The primer sets used were: P1:
primer set#1, Forward CTCATGGCAATGGGTTTTCT and Reverse
TGCATGATATGCAGTCCACA; P2: primer set#2, Forward AGAGGGGA-
GAACCAAGCATT and Reverse AGGGTCGTGGAAGGAAGTTT; P3: pri-
mer set#3, Forward CAAGGATTCCCTCGACTTGA and Reverse
CACGGACGTACACACACACA; P4: primer set#4, Forward GGCTGGA-
CACTGAAATGAGG and Reverse AAGGCTGTCAAGAGGCAAAA; P5:
primer set#5, Forward CTTGTGGGCATTTAGGCATT and Reverse TCA-
GACCTGAGCTTCCTGGT; P6: primer set#6, Forward CATGGAAGCCA-
GAAGAGGTT and Reverse AGCATGCCAAGATCCTATGC; Gli1 Gli3-ChIP
site, Forward GGACAAAGAGACCTGGGACA and Reverse AGGA-
GATGCTCTGACGCCTA; Ptch1 Gli3-ChIP site, Forward AGGCCTGCAC-
CAATAATGAC and Reverse TCCTTGCTCGCCTCTTTAAC and Baseline,
Forward CTGGCCTCCATACACACATA and Reverse AGTCAGCAGGATC-
CACACTT. The enrichments were calculated by the delta(delta)Ct
method and the enrichment levels of each primer set are shown as
Log2 values.
Cell-based luciferase reporter assay
The 2880 bp promoter sequence (mm99chr15:56525549–
56528428) of Has2 was generated by PCR and cloned upstream
of the luciferase reporter in pGL3 Basic plasmid (Promega, WI).
Primers used were as follows: Forward: ttgtctcgagTATGAATG-
CATCAACGATAAACG and Reverse: atttaagcttCTTGTTCAGCTCCTG-
CTCATAGA. Mutations at putative Gli binding sites (M1:
GCCCACCCA to GCCagCtgA; M2: GACCACACA to GACagCtgA) were
generated using a QuikChange mutagenesis kit (Stratagene, CA).
Luciferase assays were performed essentially as previously
described (Huang et al., 2010), using the Promega Dual Luciferase
Reporter Assay system (Promega, WI). All reporter assays were
normalized using Renilla luciferase as internal control. Each data
point represents the mean of triplicate wells with error bar
representing the standard deviation (SD).
Skeletal staining
Whole-mount skeletal staining with Alcian blue and Alizarin
red to visualize cartilage and mineralized bone was performed as
described (Chiang et al., 2001).
Micromass culture
Micromass cultures were prepared from E11.5 hindlimbs as
previously described (Ahrens et al., 1977; James et al., 2005;
Stanton et al., 2004). Dissociated cells were resuspended in
growth medium at a concentration of 2107 cells/ml and spotted
as 10 ml droplets onto 24-well plates. Cells were allowed to
adhere for 2 h at 37 1C, then 500 ml of 1:1 DMEM/F-12 medium
containing 10% FBS was added. Growth medium was replaced
every other day. At day 7 after seeding, micromass cultures were
collected for Alcian blue staining or Col2a1 micromass whole
mount in situ hybridization according to published methods
(Cash et al., 1997).Results
Has2 expression in the posterior limb bud mesenchyme
is dependent on signaling Shh
In an effort to identify downstream targets of Shh signaling,
we performed microarray analysis on an Affymetrix Exon array
using total RNAs extracted from the anterior and posterior halvesof E10.5 mouse limb buds (Fig. 1A). We identiﬁed Hyaluronan Acid
Synthase 2 (Has2), which was upregulated 1.35 fold in the poster-
ior limb, as a candidate gene regulated by Shh signaling. In this
screen, other known Shh target genes that were upregulated in
the posterior limb include Ptch1 (2.23 fold) and Gli1 (1.54 fold).
RT-PCR analysis conﬁrmed the enriched posterior expression of
Has2 in developing limb buds, as were Shh and Gli1 (Fig. 1B). RNA
in situ hybridization revealed that Has2 mRNA expression starts
as early as E9.5 and its dynamic expression domain expands with
limb growth but is restricted posteriorly from E9.5 to E11.5
(Fig. 1C and J), although low level expression in the proximal
region adjoining the body wall can be detected (* in Fig. 1C, G and
K). Has2 expression in the hindlimb was consistently lower than
that in the forelimb, which is in agreement with the fact that
there is 12 h delay in the development of the hindlimb
compared to forelimb. At E12.5, Has2 expression becomes largely
restricted to the condensing digit mesenchyme (Fig. 1O and P). To
determine whether Has2 expression is dependent on Shh signal-
ing, we examined Has2 mRNA expression in Shh/ mutants.
Has2 expression is dramatically reduced in Shh/ mutant limb
buds at E10.5 (Fig. 1M and N) and E11 (Fig. 1Q and R) whereas its
most proximal expression abutting the body wall remains (* in
Fig. 1M and Q). Similarly, at E12.5 Has2 expression in the distal
limb is largely absent but low level expression persists in the
proximal region of the autopod (Fig. 1Y and Z). These observations
strongly suggest that Has2 expression depends on Shh signaling.
Has2 expression in the anterior limb bud is suppressed
by Gli3 repressor
The patterning function of Shh is mainly mediated by Gli3 in
the limb. In the presence of Shh signaling, the full-length form of
Gli3 protein (Gli3-FL) is activated and functions as a transcrip-
tional activator (Gli3A). In the absence of Shh signal, as in the
anterior limb bud, Gli3-FL is cleaved into a repressor form (Gli3R)
where it suppresses the expression of Shh-responsive genes
(Litingtung et al., 2002; te Welscher et al., 2002). By examining
Has2 mRNA expression in Gli3xt mutants, which lack Gli3 func-
tion, we identiﬁed an ectopic expression domain in the anterior
margin of the limb underlying the AER (Fig. 1S and T, arrows),
indicating that Gli3R represses Has2 expression in the anterior
limb. This ectopic Has2 expression persisted in Shh/;Gli3xt
double mutants (Fig. 1U and V, arrows), suggesting that activation
of anterior Has2 expression does not require Shh pathway
activation and can be activated by Gli3R derepression. However,
the posterior expression of Has2 in Shh/; Gli3xt double mutant
limbs was reduced, suggesting a GliA contributes quantitatively
to normal expression levels (Fig. 1U and V). Together, these data
suggest that Gli activators are likely to play a role, in addition to
Gli3R, in regulating Has2 expression in the limb.
Has2 is a direct target of Gli transcription factors
Based on our genetic data, we hypothesized that Shh signaling
directly regulates Has2 expression in early limb development. The
Gli transcription factors are Shh signaling effectors and have DNA
binding zinc ﬁnger domains to bind to the consensus sequence
TGGGTGGTC on target genes to initiate or suppress transcription
(Hallikas et al., 2006; Kinzler and Vogelstein, 1990; Vokes et al.,
2007, 2008; Vortkamp et al., 1995). Through in silico analysis, we
identiﬁed two such consensus sequences within the 3 kb Has2
regulatory region, one at 646 bp (Gli-binding site 1,GBS1) and
the other at þ504 bp (GBS2) from the Has2 transcriptional start
site (þ1) (Fig. 2A and B).
To determine if these binding sites are capable of responding to
Gli1 activation, we generated Has2 reporter constructs by cloning
Fig. 1. Has2 is regulated by Shh signaling in the limb bud. (A) E10.5 limb illustration with posterior domain (P), anterior domain (A) and the Zone of polarizing activity
(ZPA). For anterior versus posterior tissue analysis, the limb was bisected at the midline (dotted line). (B) RT-PCR of anterior and posterior halves of limb buds showing
increased expression of Shh, Gli1 and Has2 in the posterior domain. Has2 expression in mesenchyme of forelimb (C, E, G and I) and hindlimb buds (D, F, H and J) from E9.5 to
E11.5 by whole mount RNA in situ hybridization. Posterior Has2 expression is undetectable in E10.5 Shh/ (M and N) compared with WT (K and L) limb buds. At E11,
posterior Has2 expression is barely detectable in Shh/ (Q and R) compared with WT (O and P) limb buds. Has2 expression is expanded anteriorly in Gli3xt mutant limb
buds at E11 (S and T, arrows) compared with wildtype (O and P). Note diminished Has2mRNA in posterior limbs of Shh /;Gli3xt double mutants while expanded anterior
Has2 remains comparable to Gli3xt limbs (U and V, arrows). Low level Has2 expression in the most proximal region adjoining the body wall can be detected in WT (C, G, K
and *) and this expression is unaltered in Shh/ (M, Q and *). (W–Z) At E12.5, Has2 expression is mostly conﬁned to the condensing digit mesenchyme (W and X), and this
patterns of expression is largely absent in Shh mutants although low level Has2 expression persists in the proximal region of the autopod (Y and Z). Scale bar, 75 mm.
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Fig. 2. Gli transcription factors directly regulate Has2 promoter activity. (A) Prediction in silico identiﬁed two potential Gli-binding sites, which are highly conserved in
mammals, in the Has2 promoter. (B) Illustration of genomic Has2 regulatory region; 3.0 kb Has2 regulatory region was used for luciferase assays. P1 through P6 were
target sequences used to identify in vivo Gli binding by chromatin immunoprecipitation (ChIP). Note that the 50 untranslated region (50 UTR) spans exon 1 of Has2.
(C) Reporter constructs used in luciferase assays. 3.0 kb Has2 regulatory region was subcloned into pGL3 luciferase plasmid (pHas2). Potential Gli binding motif was
singly mutated (pHas2m1, pHas2m2) or doubly mutated (pHas2m1/2). (D) Normalized luciferase values obtained when 3T3 cells were cotransfected with various
derivatives of Has2 luciferase reporter with or without Gli1 expression construct. (E) 3 kb Has2 promoter is sufﬁcient to direct Cherry reporter expression in the posterior
limb mesenchyme. (F) FlagGli3 ChIP for in vivo detection of Gli3 binding to Has2 promoter. Regions spanning the two potential Gli binding motifs (P2–P4) are substantially
enriched by 30–60 folds, similar to enrichment for positive control loci Gli1 and Ptch1. The positive control regions are validated Gli3 binding regions near the Gli1 and
Ptch1 loci (Vokes et al., 2008). ChIP1, ChIP2 and ChIP3 represent three independent biological samples of anti-Flag ChIP using E11.5 Prx1Cre; RosaGli3TFlagc/c limb buds. Ctrl
ChIP represents same stage wildtype limb buds. All assays were performed in triplicate and error bars represent the standard error of mean.
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(Fig. 2B and C). The Has2 reporter, either unaltered or containing
mutation at one or both GBSs (Fig. 2C), was then co-transfected with
Gli1-expressing or control vector into Shh-responsive 3T3 cells
(Taipale et al., 2000). Consistent with the presence of GBSs, we
observed signiﬁcant induction of luciferase activity by Gli1 (Fig. 2D).
Importantly, mutations in either or both GBSs reduced reporter
activity to basal level, indicating that these sites are necessary for
Gli1 activation and may function cooperatively (Fig. 2D).
We next performed transgenic analysis to further characterize
the Has2 promoter fragment and found that it contains the
necessary cis-regulatory elements to direct expression of a
reporter gene in the posterior limb mesenchyme (Fig. 2E), reveal-
ing the relevance of this region in the context of limb develop-
ment and Shh regulation.
To determine whether Gli can directly bind to GBSs at the Has2
promoter region in vivo, we utilized Prx1-cre; RosaGli3TFlagc/c
transgenic embryos in which FLAG-tagged Gli3 repressor is
expressed under the control of ubiquitous Rosa26 promoter which
is selectively activated in the early limb mesenchyme by Prx1-cre
(Vokes et al., 2008). We designed several q-PCR primer sets
within the Has2 regulatory region, P1 through P6 (Fig. 2B), and
performed ChIP using antibody against the FLAG epitope followed
by q-PCR analysis on Gli3-bound chromatin to determine enrich-
ment of PCR products. Regions spanning the two GBSs (P2–P4)
were enriched by 30–60 folds, similar to enrichment for known
Gli target genes Gli1 and Ptch1 (Fig. 2F). In contrast, regions tested
that were outside the GBSs either 2.8 kb upstream (P1) or 3.0 kb
downstream (P6) showed no enrichment, indicating that Gli binds
directly to this regulatory region of Has2 in vivo (Fig. 2F). This is
consistent with Gli3T binding observed at this site in a previously
published genomic dataset (Vokes et al., 2008).
Has2 conditional mutants display mispatterning of joints
and defective chondrogenesis
To elucidate the role of Shh-induced Has2 in early limb
development, we generated a Has2 conditional knockout allele
(Has2ﬂ) to circumvent the early lethality of Has2 null mutants
(Camenisch et al., 2000) (Fig. S1). We selected Hoxb6-cre to
inactivate Has2 function in the early limb mesenchyme based
on the observations that Hoxb6-cre is more effective than Prx1-cre
in abrogating gene function in early limb buds when crossed to
various conditional mutants (Li et al., 2005; Lowe et al., 2000;
Scherz et al., 2007; Yu and Ornitz, 2008; Zhu et al., 2008). Because
the rostral limit of Hoxb6 expression domain is conﬁned to the
posterior forelimb, all analyses were performed in hindlimbs
except where noted. Indeed, skeletal preparation of newborn
Hoxb6Cre;Has2f/ (hereinafter referred to as Has2cko) hindlimbs
showed much more severe phenotype than previously described
(Fig. 3A and B) (Matsumoto et al., 2009). Focusing on the digits,
the mutants displayed longitudinally oriented cavities that split
proximal and medial phalanges (Fig. 3E, E0 versus F, F0). As
expected, the digit defect in the forelimb is restricted to the
posterior digits (Fig. 3C and D). Histological staining at E16.5
showed that the space adjoining the split phalanges is occupied
by distinct loosely associated mesenchymal cells that are remi-
niscent of cells at interphalangeal joints (Fig. 3 G, G0 versus H, H0).
Additionally, the mutant digits displayed disorganized cartilage
nodules, suggesting a role of Has2 in chondrogenesis (Fig. 3F, F0, H,
H0). Consistent with this ﬁnding, limb micromass cultures of
Has2cko followed by Alcian blue staining or Col2a1 (type II
collagen) expression revealed striking loss of cartilage-forming
potential (Fig. 3I, J and K, L).
The ﬁrst histological indication of synovial joint formation is
the appearance of ﬂattened cells at a stereotypic joint locationknown as the interzone at E12.5 in mouse digits. As develop-
ment proceeds, the interzone undergoes cavitation, a process
where physical separation of opposing skeletal elements occurs
(Khan et al., 2007). While the mechanism involved in joint
forming activities remains to be fully deciphered, both pro-
grammed cell death and Erk activation have been implicated in
this process (Fernandez-Teran et al., 2006; Pitsillides, 2003;
Pitsillides and Ashhurst, 2008; Seo and Serra, 2007). Because
Has2cko mutants displayed perpendicularly oriented joint cavities
in the digits, we sought to determine whether there was a similar
shift in the expression pattern of pErk and cleaved Caspase 3 for
cell death. At E14.5, p-Erk (Fig. 3M and M0) and cleaved Caspase-3
(Fig. 3O and O0) immunoreactivities are normally restricted to the
joint perpendicular to the digit shafts but these expressions were
mislocalized along the longitudinal axis in Has2cko mutant digits
(Fig. 3N, N0, P and P0). Therefore, the disruption of Has2 function
leads to ectopic joints along the digit rays.
Has2 is required for positioning the interzone
To evaluate the effect of Has2 deﬁciency on joint development in
detail, we examined the expression of Gdf5, an early joint-speciﬁc
marker (Koyama et al., 2008; Storm and Kingsley, 1996). Gdf5
expression in the autopod is ﬁrst detectable at E12 in the
perichondrium bordering the condensing digit rays (Storm and
Kingsley, 1996) (Fig. S2). As development proceeds, perichondrial
Gdf5 expression diminishes while interzone expression becomes
more prominent (Fig. 4A, C and E). In Has2cko mutants, however, we
observed much broader expression of Gdf5 in the interzone at E12.5
(Fig. 4B) although perichondrial expression is initiated normally
(Fig. S2). By E13, the aberrant Gdf5 expression became more
pronounced, as evidenced by longitudinal stripes of presumptive
joint progenitors bisecting the proximal/medial phalanges and this
pattern persisted throughout joint development (Fig. 4D and F).
The expression of other joint markers such as Wnt4 (Fig. 4O
and P) and Chordin (Fig. 4Q and R), were also altered in Has2cko
mutant hindlimbs as highlighted by longitudinal shift in their
expression pattern when compared to control. Noggin expression
in condensing cartilage also highlights the misplacement of
phalangeal joints at E14.5 in Has2cko hindlimbs (Fig. 4N) com-
pared with wildtype showing clear demarcation of the joint
region (Fig. 4M). Likewise, Sox9 expression from E12.5 to E13.5
in condensing cartilage mesenchyme highlights aberrant joint
formation and longitudinal shift in Has2cko (Fig. 4H, J and L)
compared with wildtype joints (Fig. 4G, I and K; arrows showing
normal joint location). We note that Sox9 expression in digit rays
in hindlimb buds of WT and Has2cko at E12 were comparable
suggesting that commitment of mesenchymal cells to the chon-
drocytic lineage was not affected by loss of Has2 expression
(Fig. S2). We also determined the status of cell proliferation using
mitotic marker phosphorylated-Histone 3 in E12.5 and E13.5
hindlimbs (Fig. S3). We did not ﬁnd signiﬁcant alteration in cell
proliferation at these stages compared to wildtype when joint
defects were already apparent in Has2cko limb buds.
Disruption of CSPG-link protein-hyaluronan aggregates and impaired
phalangeal mesenchymal condensation in Has2cko
The profound joint patterning defects observed in our Has2
conditional mutants are strikingly similar to mouse mutants that
are either deﬁcient in CSPG or imbalanced in proteoglycan
sulfation (Sohaskey et al., 2008; Wilson et al., 2012). We therefore
examined whether CSPG development is affected in Has2cko. At
pH 2.5, Alcian blue stains most acidic proteoglycans, while at pH1
only sulfated proteoglycans are stained (Lev and Spicer, 1964).





























































Fig. 3. Has2cko mutant hindlimbs display chondrogenesis and joint positioning defects. Whole-mount skeletal elements of P0 wild-type and Has2cko forelimbs (A) and
hindlimbs (B) stained with Alizarin red and Alcian blue. Severe cartilage reduction and joint positioning defect are apparent in P0 Has2cko digits (D, F, F’) when compared to
wildtype (C, E, E’); note that interphalangeal joints highlighted by brackets are perpendicularly shifted in Has2cko mutants. Hematoxylin and Eosin staining of E16.5
hindlimb sections (G and H), with higher magniﬁcation view of joint cavities (G0 and H0). In addition to aberrant joint formation, the mutants (H and H0) also show
prominent change in phalangeal cartilage nodule organization indicating defective chondrogenesis. Has2cko limb micromasses J and L) show reduced chondrocyte
differentiation while wildtype (I and K) display robust capacity to differentiate as shown with Alcian blue staining (I and J) and Col2a expression (K and L). Sections of E14.5
digits immunostained with p-Erk1/2 (M and N) and cleaved-Caspase 3 (O and P) showing ectopically expanded expression of p-Erk in Has2cko digits (N0 , arrows) and
likewise cleaved Caspase 3 is also expanded (P0 , arrows). Note that this orthogonally shifted pattern in Has2cko agrees with the ectopic positioning of Gdf5-expressing joint
cells (G0 versus H0). In contrast, wildtype littermates show p-Erk (M and M0) and cleaved Caspase 3 (O and O0) expressions conﬁned to cells in the normal joint interzone (M0
and O0). Scale bar, 500 mm (white) and 50 mm (black).
J. Liu et al. / Developmental Biology 375 (2013) 160–171166Has2cko condensing digit rays while the interdigital mesenchyme
acquired Alcian blue staining at E12.5 (Fig. 5B and C, arrows),
suggesting loss of CSPG integrity and its aberrant distribution in
Has2cko hindlimbs. Note that in the wildtype, Alcian blue staining
is strong and conﬁned to digits, with no apparent staining in the
interdigital space (Fig. 5B, arrows). Similarly, CSPG immunostain-
ing was strongly reduced in Has2cko condensing digits when
compared to control digits (Fig. 5E versus D). Moreover, we
observed striking CSPG labeling in the interdigital mesenchyme
in Has2cko (Fig. 5E0, arrow), which is not evident in wildtype
(Fig. 5D0, arrow), suggesting loss of tethering resulting in aberrant
distribution of CSPG. This notion is in agreement with the factthat HA is required for CSPG assembly and retention in the ECM
(Day, 1999; Hardingham, 1979; Knudson, 1993; Kochhar et al.,
1984; Maleski and Knudson, 1996b; Morgelin et al., 1994, 1988;
Seyfried et al., 2005).
Aggrecan is a high molecular mass HA-binding CSPG abundant
in cartilage pericellular matrix and forms an aggregate network
with HA (Day, 1999; Hardingham, 1979; Hardingham and Fosang,
1992; Lee et al., 1993; Morgelin et al., 1994, 1988). Immunolabel-
ing for aggrecan was reduced in the condensing digits (Fig. 5F and
G) but showed enhanced ectopic localization in the interdigital
mesenchyme at E13.5 (Fig. 5F0 and G0, arrows). Similarly, link
























Fig. 4. Joint markers indicate aberrant positioning of the interzone in Has2cko. Section in situ hybridization analysis for Gdf5 (A–F) and Sox9 (G–L) expression in wild-type
(A, C, E, G, I and K) and Has2cko (B, D, F, H, J and L) limbs. The joint defects in Has2cko can be detected as early as E12.5 when Gdf5 expression, which highlights the position of
forming interzone (A, arrow), is expanded (B). The aberrant Gdf5 expression becomes progressively more severe (C versus D) and by E13.5 the interzone is clearly
orthogonally shifted in Has2cko mutant limbs (E versus F). Similarly, Sox9 expressions in the chondrocytic domain also highlight the defective interzone formation in
Has2cko (G–L). Arrows mark interzone where Sox9 expression is absent, and this Sox9 negative zone is expanded in Has2cko digits. Similar to Sox9, Noggin expression is
absent in the center of the condensing chondrocytes in Has2cko digits but instead surrounds the orthogonally shifted joint (compare M and N). RNA in situ hybridization
analyses showing ectopic expression of additional joint interzone markers, Wnt4 and Chordin, in Has2cko hindlimb digits (P and R) compared with wildtype (O and Q) at
E14.5. Scale bar, 50 mm.
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densing digits and distributed aberrantly in the interdigital
mesenchyme of Has2cko limbs (Fig. 5H, I and H0, I0, arrows).
Collectively, these ﬁndings highlight a crucial role for HA in
assembling the pericellular CSPG matrix for proper mesenchymal
condensation and subsequent interzone positioning.Discussion
Chondrogenic differentiation and joint patterning in the devel-
oping vertebrate limb are dependent on cell-matrix interactions.Previous studies suggested that inductive signals regulate limb
bud subridge mesoderm to maintain a relatively high rate of HA
synthesis (Knudson and Toole, 1988). Consistent with this, bFGF
was subsequently shown to stimulate HA synthesis in cultured
chick embryonic limb mesodermal cells (Munaim et al., 1991).
Other in vitro studies also showed that Hyaluronan synthase (Has)
expression can be regulated by growth factors and cytokines
(Jiang et al., 2011). However, the signal that induces the expres-
sion of Has during limb development is not known. Our study
reveals that the molecular control of Has2 gene expression in the
early developing limb is Shh signaling. We demonstrated by
genetic and molecular analyses that Shh signaling directly
Fig. 5. Loss of Has2 disrupts CSPG, aggrecan and link protein level and distribution. Alcian blue staining of sulfated proteoglycans in E12.5 wild-type and Has2cko embryos.
Whole-mount preparation showed comparable staining except in the hindlimb (A). This is better shown in higher magniﬁcation view in which Has2cko digits lack intense
Alcian blue staining seen in wildtype (B) but show striking acquisition of staining in the interdigital regions (arrows in C). Immunostaining of Has2cko (E, E0 , G, G0 , I and I0)
hindlimb sections compared with wild-type (D, D0, F, F0 H and H0) for total CSPG (D, D0 , E and E0), aggrecan (F, F0 , G G0 and D0) and link protein (H, H0 , I and I0) showing
markedly reduced expression of all these components, which normally form aggregates with HA, in Has2cko hindlimb condensing digits (dotted line). CSPG is aberrantly
distributed to the interdigital mesenchyme in Has2cko limbs (compare arrow in D0 and E0), consistent with interdigital Alcian blue staining pattern in C, arrows. In contrast,
CSPG is conﬁned to condensing digits in wildtype with no apparent interdigital staining (arrow in D0). Has2cko hindlimb buds also appear to have acquired interdigital
staining for aggrecan (G0, arrow) and link protein (I0, arrow) which are conﬁned to digits in wildtype. Scale bar, 150 mm.
J. Liu et al. / Developmental Biology 375 (2013) 160–171168regulates Has2 expression during early limb development. While
Has2 expression in the posterior limb mesoderm is dependent on
both positive Shh induction and Gli3R derepression, its expression
in the anterior mesoderm is induced by Gli3R derepression. It is
interesting to note that Has2 expression seems to occur in two
phases in the developing autopod; early Shh-induced Has2 at
E9.5–12.5 (Fig. 1) and a late-induced phase at around E14.5–
E16.5, likely independent of Hh, in presumptive joints and
perichondrium where Hh pathway is not activated (Dy et al.,
2010). Because aberrant interzone development occurs as early as
E12.5 (Fig. 4B), we propose that the regulation of Has2 by Shh
signaling is important in digit joint patterning. However, our
study cannot rule out the contribution of late-phase Has2 expres-
sion in joint development. We note that residual Has2 expression
still persists in Shh mutant limbs (Fig. 1), which may explain
the relatively normal expression of Gdf5 in the single un-ossiﬁed
digit 1 (Chiang et al., 2001).Our ﬁnding imparts new insights into the role of Shh signaling
in HA extracellular matrix induction which functions in tissue
injury and repair (Jiang et al., 2007), and has long been implicated
in tumorigenicity (Adamia et al., 2005; Bourguignon, 2008; Toole
and Hascall, 2002; Whatcott et al., 2011). Has/HA has been
implicated in epithelial transformation, support of the cancer
stem cell niche, regulating tumor-stromal interaction and growth
and progression of a number of tumor types (Bernert et al., 2011;
Bharadwaj et al., 2009; Kobayashi et al., 2010; Kosaki et al., 1999;
Kramer et al., 2011; Li and Heldin, 2001; Li et al., 2007; Okuda
et al., 2012; Paiva et al., 2005; Simpson, 2006; Simpson et al.,
2001, 2002; Udabage et al., 2005; Zoltan-Jones et al., 2003).
Our ﬁnding that Shh signaling induces Has2/HA expression
can potentially be relevant in other developmental, injury or
disease contexts where the Shh pathway is activated. Interest-
ingly, Rhamm which encodes a hyaluronan-mediated motility
receptor is also signiﬁcantly upregulated in Shh pathway driven
J. Liu et al. / Developmental Biology 375 (2013) 160–171 169medulloblastoma (Read et al., 2009). In addition, Has2 is upregu-
lated in microarrays from Shh-driven cerebellar tumors (Chiang,
unpublished observation). It remains to be determined if Has2 is a
target of Shh signaling uniquely during limb development or in
the broader context of Shh-driven pathologies where the stromal
microenvironment and extracellular matrix play critical roles in
disease progression.
Our ﬁnding underscores the essential role of Shh signaling in
regulating the composition and function of the early limb ECM
scaffold, a novel ﬁnding that stands in contrast to its known role
in promoting cell proliferation. We generated Has2 conditional
mutants to determine the signiﬁcance of Shh-induced Has2
during limb development. A previous study had shown that
Has2 is required for chondrocyte maturation and joint formation
(Matsumoto et al., 2009). Our study is consistent with their
ﬁndings, but provides additional insights regarding the role of
Has2 in CSPG complex assembly and digit patterning. We found
that our Has2 mutants displayed a more severe phalangeal
phenotype, with orthogonal shifting of digit interzones that
progressively developed into joint cavities. This ﬁnding is strongly
reminiscent of mutants that are defective in chondroitin sulfate
synthesis or metabolism, and therefore underscores a central role
of HA in the assembly of CSPG-aggregate complexes (see below).
It is not entirely clear as to why our mutant phenotype is more
severe than the previously reported Has2 mutants. Because both
alleles were designed to remove exon 2, it is unlikely that there
are allele differences. One possibility is that we used Has2ﬂ/ as
opposed to Has2ﬂ/ﬂ (Matsumoto et al., 2009). Alternatively, there
is evidence to suggest that the Prx-cre line does not efﬁciently
excise target sequences when compared to the Hoxb6-cre line
prior to E10.5 (Li et al., 2005; Scherz et al., 2007; Yu and Ornitz,
2008; Zhu et al., 2008).
The limb bud mesenchyme synthesizes CSPGs in prechondro-
genic condensations (Hascall et al., 1976; Shinomura et al., 1984;
Tsonis and Walker, 1991). We observed early changes in the pattern
and expression of CSPG, aggrecan and link protein with signiﬁcantly
less labeling indicating reduced and diffuse deposition in Has2cko
condensing digits. This ﬁnding is consistent with the role of HA in
assembling the HA-CSPG network stabilized by link proteins (Day,
1999; Hardingham, 1979; Hardingham and Fosang, 1992; Kohda
et al., 1996; Lee et al., 1993; Morgelin et al., 1994, 1988; Seyfried
et al., 2005). Various HA perturbation studies in limb cultures
suggested that HA promotes assembly and retention of CSPG for
pericellular matrix organization and HA plays a role in cell–cell
adhesion and interaction during mesenchymal condensation
(Knudson, 1993; Knudson et al., 1999; Knudson and Toole, 1985;
Kochhar et al., 1984; Maleski and Knudson, 1996a,b). Recent
ﬁndings in vivo provide evidence for the essential role of CSPG
and link protein in chondrogenesis. Mice deﬁcient in CSPG biosynth-
esis developed skeletal dysplasia (Hiraoka et al., 2007). Abrogating
Chondroitin sulfate synthase (Chsy1) or Impad1/Jaws resulted in
impaired CSPG sulfation and defects in chondrocyte differentiation
andmaturation (Sohaskey et al., 2008;Wilson et al., 2012). Mutation
of human IMPAD1 leads to chondrodysplasia and joint abnormalities
(Sohaskey et al., 2008; Vissers et al., 2011). Ablating link protein
resulted in severe defects in chondrocyte organization, differentia-
tion and maturation (Watanabe and Yamada, 1999). Indeed, our
Has2cko limbs, with ectopic joints orthogonally shifted along the
longitudinal axis, bear striking similarity to mutant limbs with
impaired CSPG synthesis or sulfation (Sohaskey et al., 2008;
Wilson et al., 2012), suggesting a central role of HA in the assembly
of CSPG-aggregate complexes in vivo.
In addition to mutants that disrupt the composition of the
ECM, inactivating Hypoxia-inducible factor 1 a (Hif1a) gene in the
limb also produced longitudinal cavities representing aberrant
joint patterning (Amarilio et al., 2007; Provot et al., 2007).However, the expression of the Hif1a target gene Pgk1 or EF5 (a
chemical probe for hypoxia) were not signiﬁcantly changed in
Has2cko limbs (Fig. S4). Together, these results suggest that the
joint phenotype observed in Has2cko digits is not caused by
changes in hypoxia regulation. While the precise mechanism by
which Has2 or CSPG deﬁciency leads to ectopic joint formation
remains to be determined, it has been suggested that early Gdf-5-
expressing cells migrate from the perichondrium region into the
perimeter of developing cartilage (Paciﬁci et al., 2006; Storm and
Kingsley, 1996). Gdf5 is expressed in the perichondrium as well as
interzone, and genetic fate mapping studies indicated that Gdf5-
expressing cells contribute primarily to joint tissues including
articular cartilage and synovial lining (Koyama et al., 2008). Given
that Gdf5 expression in the perichondrium is initiated normally in
Has2cko, it is possible that disruption of HA-CSPG complex in
condensing prechondrocytes may permit aberrant migration and
subsequent positioning of interzone precursor cells. In summary,
we have established Has2 as a direct downstream target of Shh
signaling pathway and demonstrated that it is required for
interzone positioning. Our ﬁnding underscores the essential role
of Shh signaling in regulating the composition and function of the
early limb ECM scaffold, a novel ﬁnding that stands in contrast to
its known role in promoting cell proliferation.Acknowledgments
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